Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.11
HRC's Cash-to-Debt is ranked lower than
94% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. HRC: 0.11 )
Ranked among companies with meaningful Cash-to-Debt only.
HRC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.62 Max: N/A
Current: 0.11
Equity-to-Asset 0.29
HRC's Equity-to-Asset is ranked lower than
88% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. HRC: 0.29 )
Ranked among companies with meaningful Equity-to-Asset only.
HRC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17  Med: 0.33 Max: 0.67
Current: 0.29
0.17
0.67
Interest Coverage 2.95
HRC's Interest Coverage is ranked lower than
92% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.06 vs. HRC: 2.95 )
Ranked among companies with meaningful Interest Coverage only.
HRC' s Interest Coverage Range Over the Past 10 Years
Min: 2.55  Med: 12.51 Max: 25.97
Current: 2.95
2.55
25.97
Piotroski F-Score: 6
Altman Z-Score: 2.43
Beneish M-Score: -2.68
WACC vs ROIC
5.41%
6.99%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 9.79
HRC's Operating Margin % is ranked higher than
63% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. HRC: 9.79 )
Ranked among companies with meaningful Operating Margin % only.
HRC' s Operating Margin % Range Over the Past 10 Years
Min: -27.59  Med: 8.79 Max: 13.04
Current: 9.79
-27.59
13.04
Net Margin % 5.44
HRC's Net Margin % is ranked higher than
58% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. HRC: 5.44 )
Ranked among companies with meaningful Net Margin % only.
HRC' s Net Margin % Range Over the Past 10 Years
Min: -29.2  Med: 6.76 Max: 14.05
Current: 5.44
-29.2
14.05
ROE % 12.11
HRC's ROE % is ranked higher than
73% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. HRC: 12.11 )
Ranked among companies with meaningful ROE % only.
HRC' s ROE % Range Over the Past 10 Years
Min: -47.88  Med: 11.51 Max: 19.03
Current: 12.11
-47.88
19.03
ROA % 3.38
HRC's ROA % is ranked higher than
56% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. HRC: 3.38 )
Ranked among companies with meaningful ROA % only.
HRC' s ROA % Range Over the Past 10 Years
Min: -27.72  Med: 6.31 Max: 10.48
Current: 3.38
-27.72
10.48
ROC (Joel Greenblatt) % 33.63
HRC's ROC (Joel Greenblatt) % is ranked higher than
79% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. HRC: 33.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HRC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -66.76  Med: 24.57 Max: 35.12
Current: 33.63
-66.76
35.12
3-Year Revenue Growth Rate 11.90
HRC's 3-Year Revenue Growth Rate is ranked higher than
80% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. HRC: 11.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HRC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 5.2 Max: 16.2
Current: 11.9
0
16.2
3-Year EBITDA Growth Rate 13.60
HRC's 3-Year EBITDA Growth Rate is ranked higher than
71% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. HRC: 13.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HRC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.1 Max: 135.9
Current: 13.6
0
135.9
3-Year EPS without NRI Growth Rate 2.20
HRC's 3-Year EPS without NRI Growth Rate is ranked lower than
55% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. HRC: 2.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HRC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.55 Max: 29.1
Current: 2.2
0
29.1
GuruFocus has detected 8 Warning Signs with Hill-Rom Holdings Inc $HRC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HRC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

HRC Guru Trades in Q2 2016

Pioneer Investments 297,393 sh (+138.20%)
Paul Tudor Jones 410,008 sh (+13.32%)
Ken Fisher 1,576,535 sh (+0.38%)
Joel Greenblatt Sold Out
David Dreman Sold Out
Chuck Royce 368,576 sh (-10.01%)
Steven Cohen 821,200 sh (-10.89%)
Jim Simons 228,300 sh (-68.93%)
» More
Q3 2016

HRC Guru Trades in Q3 2016

Joel Greenblatt 94,180 sh (New)
Pioneer Investments 412,689 sh (+38.77%)
Jim Simons 310,900 sh (+36.18%)
Ken Fisher 1,627,296 sh (+3.22%)
Chuck Royce 321,337 sh (-12.82%)
Steven Cohen 460,500 sh (-43.92%)
Paul Tudor Jones 111,625 sh (-72.77%)
» More
Q4 2016

HRC Guru Trades in Q4 2016

Joel Greenblatt 343,275 sh (+264.49%)
Paul Tudor Jones 172,256 sh (+54.32%)
Jim Simons 427,700 sh (+37.57%)
Chuck Royce 321,647 sh (+0.10%)
Steven Cohen Sold Out
Ken Fisher 1,597,159 sh (-1.85%)
Pioneer Investments 104,514 sh (-74.67%)
» More
Q1 2017

HRC Guru Trades in Q1 2017

Ken Fisher 1,569,661 sh (-1.72%)
» More
» Details

Insider Trades

Latest Guru Trades with HRC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:OTCPK:GNGBF, NYSE:STE, NYSE:CMD, NYSE:WST, NAS:ICUI, OTCPK:ANSLF, NAS:PODD, OTCPK:AMFPF, NYSE:HAE, OTCPK:TOPCF, OTCPK:SAUHY, NYSE:HYH, NYSE:GKOS, NAS:NXTM, NAS:MMSI, OTCPK:PLHNF, OTCPK:HGYMF, NAS:ATRI, NAS:IRTC, NAS:LMNX » details
Traded in other countries:HB9.Germany,
Headquarter Location:USA
Hill-Rom Holdings Inc is engaged in selling and renting patient support and near-patient technologies and services, and health information technology solutions in the U.S. and Canada.

Hill-Rom Holdings sells medical technology to healthcare providers. The advancing mobility segment contributes the majority of revenue and includes bed systems and mobility solutions. The wound care and prevention segment sells products for pulmonary, wound, and bariatric conditions, such as ventilators, defibrillators, and intravenous pumps. The clinical workflow segment provides technologies to improve patient and staff communication and aggregate patient data. The surgical safety and efficiency segment sells surgical tables, positioning devices, and consumables used in operating rooms. The respiratory health segment offers bronchial hygiene products for acute- and home-care patients. Hill-Rom generates the majority of its revenue in the United States.

Ratios

vs
industry
vs
history
PE Ratio 35.58
HRC's PE Ratio is ranked lower than
56% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. HRC: 35.58 )
Ranked among companies with meaningful PE Ratio only.
HRC' s PE Ratio Range Over the Past 10 Years
Min: 7.22  Med: 19.08 Max: 97.93
Current: 35.58
7.22
97.93
Forward PE Ratio 18.98
HRC's Forward PE Ratio is ranked higher than
87% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.42 vs. HRC: 18.98 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 35.58
HRC's PE Ratio without NRI is ranked lower than
56% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.38 vs. HRC: 35.58 )
Ranked among companies with meaningful PE Ratio without NRI only.
HRC' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.16  Med: 19.28 Max: 97.93
Current: 35.58
8.16
97.93
Price-to-Owner-Earnings 18.90
HRC's Price-to-Owner-Earnings is ranked higher than
77% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.93 vs. HRC: 18.90 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HRC' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.99  Med: 16.39 Max: 213.03
Current: 18.9
6.99
213.03
PB Ratio 4.25
HRC's PB Ratio is ranked lower than
55% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.56 vs. HRC: 4.25 )
Ranked among companies with meaningful PB Ratio only.
HRC' s PB Ratio Range Over the Past 10 Years
Min: 0.58  Med: 2.6 Max: 4.3
Current: 4.25
0.58
4.3
PS Ratio 1.90
HRC's PS Ratio is ranked higher than
69% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. HRC: 1.90 )
Ranked among companies with meaningful PS Ratio only.
HRC' s PS Ratio Range Over the Past 10 Years
Min: 0.4  Med: 1.33 Max: 1.95
Current: 1.9
0.4
1.95
Price-to-Free-Cash-Flow 23.24
HRC's Price-to-Free-Cash-Flow is ranked higher than
73% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.88 vs. HRC: 23.24 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HRC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.32  Med: 12.71 Max: 41.43
Current: 23.24
3.32
41.43
Price-to-Operating-Cash-Flow 16.56
HRC's Price-to-Operating-Cash-Flow is ranked higher than
64% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.90 vs. HRC: 16.56 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HRC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.32  Med: 9.96 Max: 68.63
Current: 16.56
3.32
68.63
EV-to-EBIT 26.83
HRC's EV-to-EBIT is ranked lower than
54% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. HRC: 26.83 )
Ranked among companies with meaningful EV-to-EBIT only.
HRC' s EV-to-EBIT Range Over the Past 10 Years
Min: -29.7  Med: 14.3 Max: 64.8
Current: 26.83
-29.7
64.8
EV-to-EBITDA 14.78
HRC's EV-to-EBITDA is ranked higher than
70% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. HRC: 14.78 )
Ranked among companies with meaningful EV-to-EBITDA only.
HRC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -6.5  Med: 8.4 Max: 45.5
Current: 14.78
-6.5
45.5
PEG Ratio 9.22
HRC's PEG Ratio is ranked lower than
93% of the 58 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. HRC: 9.22 )
Ranked among companies with meaningful PEG Ratio only.
HRC' s PEG Ratio Range Over the Past 10 Years
Min: 6.82  Med: 8.9 Max: 27.34
Current: 9.22
6.82
27.34
Shiller PE Ratio 77.70
HRC's Shiller PE Ratio is ranked lower than
80% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 43.41 vs. HRC: 77.70 )
Ranked among companies with meaningful Shiller PE Ratio only.
HRC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.06  Med: 23.58 Max: 78.45
Current: 77.7
4.06
78.45
Current Ratio 1.67
HRC's Current Ratio is ranked lower than
73% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. HRC: 1.67 )
Ranked among companies with meaningful Current Ratio only.
HRC' s Current Ratio Range Over the Past 10 Years
Min: 1.33  Med: 2.22 Max: 3.1
Current: 1.67
1.33
3.1
Quick Ratio 1.27
HRC's Quick Ratio is ranked lower than
67% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. HRC: 1.27 )
Ranked among companies with meaningful Quick Ratio only.
HRC' s Quick Ratio Range Over the Past 10 Years
Min: 1.15  Med: 1.79 Max: 2.72
Current: 1.27
1.15
2.72
Days Inventory 67.37
HRC's Days Inventory is ranked higher than
86% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. HRC: 67.37 )
Ranked among companies with meaningful Days Inventory only.
HRC' s Days Inventory Range Over the Past 10 Years
Min: 45.96  Med: 52.05 Max: 73.07
Current: 67.37
45.96
73.07
Days Sales Outstanding 65.46
HRC's Days Sales Outstanding is ranked lower than
56% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.76 vs. HRC: 65.46 )
Ranked among companies with meaningful Days Sales Outstanding only.
HRC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 65.46  Med: 88.77 Max: 132.28
Current: 65.46
65.46
132.28
Days Payable 33.70
HRC's Days Payable is ranked lower than
76% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.53 vs. HRC: 33.70 )
Ranked among companies with meaningful Days Payable only.
HRC' s Days Payable Range Over the Past 10 Years
Min: 29.19  Med: 39.09 Max: 50.34
Current: 33.7
29.19
50.34

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.90
HRC's Dividend Yield % is ranked lower than
63% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. HRC: 0.90 )
Ranked among companies with meaningful Dividend Yield % only.
HRC' s Dividend Yield % Range Over the Past 10 Years
Min: 0.89  Med: 1.45 Max: 6.05
Current: 0.9
0.89
6.05
Dividend Payout Ratio 0.32
HRC's Dividend Payout Ratio is ranked higher than
68% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. HRC: 0.32 )
Ranked among companies with meaningful Dividend Payout Ratio only.
HRC' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.21  Med: 0.36 Max: 1.01
Current: 0.32
0.21
1.01
3-Year Dividend Growth Rate 8.50
HRC's 3-Year Dividend Growth Rate is ranked lower than
53% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.60 vs. HRC: 8.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
HRC' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7.7 Max: 25.3
Current: 8.5
0
25.3
Forward Dividend Yield % 0.98
HRC's Forward Dividend Yield % is ranked lower than
67% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. HRC: 0.98 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.47
HRC's 5-Year Yield-on-Cost % is ranked lower than
56% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. HRC: 1.47 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HRC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.39  Med: 2.26 Max: 9.44
Current: 1.47
1.39
9.44
3-Year Average Share Buyback Ratio -3.90
HRC's 3-Year Average Share Buyback Ratio is ranked lower than
52% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.20 vs. HRC: -3.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HRC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.9  Med: 0.9 Max: 3.1
Current: -3.9
-3.9
3.1

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.67
HRC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
68% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. HRC: 1.67 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HRC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.3  Med: 0.87 Max: 9.08
Current: 1.67
0.3
9.08
Price-to-Median-PS-Value 1.45
HRC's Price-to-Median-PS-Value is ranked lower than
65% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. HRC: 1.45 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HRC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.31  Med: 0.78 Max: 1.46
Current: 1.45
0.31
1.46
Earnings Yield (Greenblatt) % 3.75
HRC's Earnings Yield (Greenblatt) % is ranked higher than
62% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. HRC: 3.75 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HRC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.5  Med: 6.6 Max: 13.3
Current: 3.75
1.5
13.3
Forward Rate of Return (Yacktman) % 7.44
HRC's Forward Rate of Return (Yacktman) % is ranked lower than
61% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. HRC: 7.44 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HRC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -21.6  Med: 3.3 Max: 18.6
Current: 7.44
-21.6
18.6

More Statistics

Revenue (TTM) (Mil) $2,631
EPS (TTM) $ 2.14
Beta0.70
Short Percentage of Float2.25%
52-Week Range $46.79 - 74.05
Shares Outstanding (Mil)65.35

Analyst Estimate

Sep17 Sep18
Revenue (Mil $)
EPS ($) 3.86 4.38
EPS without NRI ($) 3.86 4.38
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for HRC

Headlines

Articles On GuruFocus.com
Hill-Rom Introduces Monarch™ Airway Clearance System Apr 25 2017 
Hill-Rom Innovations Make Surgical Procedures Safer, More Efficient Apr 04 2017 
Lightstone Ventures Names Stacy Enxing Seng as Venture Partner Mar 02 2016 
Hill-Rom Q2 Earnings Beat Market Estimates May 09 2015 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 21,029 Shares Dec 07 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 18,893 Shares Dec 03 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 20,005 Shares Nov 23 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 9,757 Shares Nov 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 33,670 Shares Nov 12 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 25,967 Shares Nov 08 2010 

More From Other Websites
Hill-Rom tops Street 2Q forecasts Apr 28 2017
Hill-Rom Exceeds Guidance With Strong Fiscal Second Quarter Financial Results And Raises 2017... Apr 28 2017
Integra LifeSciences (IART) Misses Q1 Earnings, Retains View Apr 27 2017
Thermo Fisher (TMO) Tops Q1 Earnings, Sales, Raises Guidance Apr 26 2017
Illumina (ILMN) Posts In-line Earnings in Q1, Margins Down Apr 26 2017
Hill-Rom Introduces Monarch™ Airway Clearance System Apr 25 2017
LabCorp (LH) Tops Q1 Earnings, Misses on Sales, Tweaks View Apr 25 2017
Hill-Rom Holdings (HRC) Q2 Earnings: A Beat in the Cards? Apr 19 2017
Medical Device Stocks to Beat Estimates this Earnings Season Apr 18 2017
Boston Scientific's Emerging Markets Grow Amid Currency Woes Apr 13 2017
ResMed's Study Results for Central Sleep Apnea Hold Promise Apr 11 2017
Hill-Rom Holdings, Inc. : HRC-US: Dividend Analysis : March 24th, 2017 (record date) : By the... Apr 10 2017
Medtronic Initiates Product Recall, A Drag on Neurosurgery Apr 10 2017
VWR Corp Continues its Acquisition Spree with MESM Buyout Apr 10 2017
Hill-Rom's Innovations Make Surgeries More Safe, Accurate Apr 07 2017
Medtronic (MDT) Less-Invasive HVAD Pump Results Positive Apr 07 2017
3 Top Medical Instrument Companies to Buy in 2017 Apr 04 2017
Hill-Rom Innovations Make Surgical Procedures Safer, More Efficient Apr 04 2017
Hill-Rom Holdings, Inc., to Host Fiscal Second Quarter 2017 Earnings Conference Call and Webcast Mar 20 2017
Hill-Rom Raises Quarterly Dividend Rate; Elects Mary Garrett and Nancy M. Schlichting To Its Board... Mar 14 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)